K. Okamura, “Addition of Sacubitril/Valsartan to Mineralocorticoid Receptor Antagonist Therapy in Primary Aldosteronism: Effects on Plasma Aldosterone Concentration and Plasma Renin Activity”, J Clin Med Res, vol. 16, no. 10, pp. 509–517, Oct. 2024, doi: 10.14740/jocmr6058.